Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
43941
Table_2_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43942
Image_8_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43943
Image_3_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43944
Table_4_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43945
Image_14_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43946
Image_11_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43947
Table_7_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43948
Table_8_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.docx
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43949
Image_7_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43950
Image_5_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43951
Image_4_Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019.JPEG
Published 2023“…</p>Results<p>Globally, the incident cases, deaths, and DALYs of digestive diseases in 2019 increased by 74.44, 37.85, and 23.46%, respectively, compared with that in 1990, with an increasing ASIR of 0.09%, as well as decreasing ASDR and ASDALYs of 1.38 and 1.32% annually. …”
-
43952
-
43953
-
43954
Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon
Published 2016“…Envenomings recorded from urban areas [Odds ratio (OR) = 0.40 (95%CI = 0.30–0.71; p<0.001)] and living in a municipality with a mean health system performance index (MHSPI >median [OR = 0.64 (95%CI = 0.39–0.75; p<0.001)] were independently associated with decreased risk of severity. …”
-
43955
-
43956
Table_2_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx
Published 2022“…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
-
43957
Table_3_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx
Published 2022“…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
-
43958
Table_1_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx
Published 2022“…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
-
43959
Table_4_Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab.docx
Published 2022“…</p>Methods<p>We performed a retrospective analysis on a cohort of patients with advanced melanoma who w0ere treated with standard I/N. …”
-
43960
DataSheet_1_Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome.docx
Published 2022“…The association remained significant after adjustment for the variables contributing to fatigue in the univariate analysis (OR [95% CI]: 0.3 [0.1-0.9], p=0.026). Accordingly, in the Dutch cohort, there was a trend of lower mental fatigue among patients carrying the TT rs9514828 BAFF genotype compared to their CC counterparts (4.1 ± 2.4 vs 6.0 ± 2.2 respectively, p=0.06). …”